✕
Free ₹200 worth HealthCash on app
Use HealthCash to order medicines, health products & much more
Confused about any medicine? Just ask Practo AIFREE
50000+ health queries resolved in last month
Chat with Practo AI on Whatsapp
Not finding what you need? Ask Practo AI
FREE
Chat with Practo AI on Whatsapp
Description
Ipranase AQ Nasal Spray is an oral inhalation medicine that is used in the treatment or prevention of bronchospasm (narrowing of the airways) associated with chronic obstructive pulmonary disease (blockage of airflow to your lungs). It works by relaxing and widening the blocked air passages of your lungs. Thus it improves the airflow to your lungs and makes breathing easier.
Ipranase AQ Nasal Spray may cause side effects like headache, cough, tiredness, pain during passing out urine, tightness in the chest, etc. Inform your doctor if these side effects persist or worsen. These side effects usually subside with time. However, consult your doctor for further assistance if they persist or worsen.
Ipranase AQ Nasal Spray is a prescription medicine. It should be used in the dose and duration advised by your doctor. For ease of remembering, use it around the same time every day. Even if you see an improvement in your condition, do not stop taking it. If you discontinue Ipranase AQ Nasal Spray early, your symptoms may recur or worsen.
Ipranase AQ Nasal Spray is not recommended if you are allergic to it. It should be taken with caution if you have glaucoma (an eye condition caused due to abnormality in the drainage system of the eye leading to nerve damage) or blockage in the bladder.
QUICK LINKS:
Substitutes
List of substitutes for Ipranase AQ Nasal Spray
Side effects
Major & minor side effects for Ipranase AQ Nasal Spray
Bladder pain
Wheezing
Shortness of breath
Ear congestion
Constipation
Headache
Unusual tiredness or weakness
Fainting
Severe eye pain
Uses of Ipranase AQ Nasal Spray
What is it prescribed for?
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that cause blockage of airflow leading to breathing-related problems. The symptoms include breathing difficulty, cough, mucous (sputum) production, and wheezing. Ipranase AQ Nasal Spray is used to prevent and treat bronchospasm (narrowing of the airways) caused due to COPD.
Rhinorrhoea
Rhinorrhoea is a condition characterised by symptoms such as a runny nose, sore throat, coughing, sneezing, etc caused due to allergies, the common cold, infections, etc. Ipranase AQ Nasal Spray is used in the treatment of Rhinorrhea and thus provides relief from such symptoms.
Asthma
Asthma is a condition in which there is inflammation (swelling and redness) of the airways characterised by breathing difficulty. Ipranase AQ Nasal Spray is used to prevent difficulty breathing, chest tightness, wheezing and coughing caused by asthma.
Concerns
Commonly asked questions
How long does it take for this medicine to take effect?
The effect of Ipranase AQ Nasal Spray can be observed as follows: Oral inhalation: the effect can be seen within 1-3 minutes. Intra-nasal route: the effect of Ipranase AQ Nasal Spray can be observed within 15 minutes.How long do the effects of this medicine last?
The effect of Ipranase AQ Nasal Spray lasts for an average duration of three to four hours.Is it safe to consume alcohol while taking this medicine?
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.Is this a habit forming medicine?
No habit-forming tendencies were reported for Ipranase AQ Nasal Spray.Can this medicine be taken during pregnancy?
Ipranase AQ Nasal Spray is not recommended for use during pregnancy unless necessary. Consult your doctor if you are pregnant before using this medicine.Can this medicine be taken while breast-feeding?
Ipranase AQ Nasal Spray is not recommended for use while breastfeeding unless necessary. Consult your doctor to understand the potential risk and benefits before using this medicine.
Allergy
Avoid using Ipranase AQ Nasal Spray if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (of the face/tongue/throat), breathing difficulty, etc.
Warnings for special population
Pregnancy
Ipranase AQ Nasal Spray is not recommended for use during pregnancy unless necessary. Consult your doctor if you are pregnant before using this medicine.
Breast-feeding
Ipranase AQ Nasal Spray is not recommended for use while breastfeeding unless necessary. Consult your doctor to understand the potential risk and benefits before using this medicine.
General warnings
Glaucoma
Ipranase AQ Nasal Spray should be used with caution if you are diagnosed with glaucoma (an eye condition caused due to abnormality in the drainage system of the eye leading to nerve damage) as this medicine may cause serious side effects and worsen your condition.
Urinary Retention
Ipranase AQ Nasal Spray should be taken with caution if you have urinary retention. Follow all the instructions given by your doctor.
Use in children
Ipranase AQ Nasal Spray is not recommended for use in children less than 18 years of age as the safety and efficacy data of use are not clinically established.
Other medicines
Ipranase AQ Nasal Spray may interact with other medicines and cause side effects. Hence, inform your doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.
Tachycardia
Ipranase AQ Nasal Spray should be taken with caution if you have irregular heartbeats, as it can worsen your condition. Follow all the instructions given by your doctor.
Missed Dose
Do not miss the dose of Ipranase AQ Nasal Spray. In case you miss a dose, take it as soon as you remember. However, if it is time for the next dose, then skip the missed dose. Do not double the dose to make up for the missed one.
Overdose
Do not take more than the prescribed dose of Ipranase AQ Nasal Spray. Seek emergency medical treatment in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Description
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Instructions
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Atropine
Clozapine
Tiotropium
Darifenacin
Disease interactions
Liver/kidney impairment
Ipranase AQ Nasal Spray should be used with caution if you have a kidney or liver condition as there is a lack of study.
Food interactions
Information not available.
Lab interactions
Information not available.
Use Ipranase AQ Nasal Spray exactly as advised by your doctor. Do not use in larger or smaller amounts than prescribed.
The prescribed dosage form, frequency, and duration of uptake are specific to your needs.
Ensure that you use Ipranase AQ Nasal Spray for the recommended duration. Do not stop the use of this medicine without consulting your doctor.
Consult your doctor if you experience any undesired effects that persist or worsen.
Follow all the instructions given in the leaflet before using it. Do not swallow or inject the solution. Avoid using Ipranase AQ Nasal Spray if the solution is not clear or colourless.
The inhaler should be washed with water and dried under sunlight. Rinse your mouth after inhalation to prevent mouth infections.
Miscelleneous
How it works
Ipranase AQ Nasal Spray works by relaxing and widening the blocked air passages of your lungs. It improves the airflow to your lungs and makes breathing easier.
Legal Status
Classification
Category
Anti Cholinergic Brochodilators, Nasal antihistamines and decongestants
Schedule
Schedule H
[Internet]. Mhra.gov.uk. 2018 [cited 29 March 2018]. Available from:
DailyMed - ipratropium bromide solution [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 29 March 2018]. Available from:
Ipratropium Oral Inhalation: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 29 March 2018]. Available from:
[Internet]. Accessdata.fda.gov. 2018 [cited 29 March 2018]. Available from:
[Internet]. Accessdata.fda.gov. 2018 [cited 29 March 2018]. Available from:
Related Questions
Information on this page was last updated on 24 Apr 2023
Disclaimer
We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.